PharmaLogic will manage and invest in building a Current Good Manufacturing Practice facility on UPMC’s campus, and the system will co-fund and “be the anchor clinical customer and provide strategic, research and operational support,” according to a news release from Pittsburgh-based UPMC.
“Under the terms of the non-exclusive agreement, PharmaLogic and UPMC will translate investigational radiopharmaceuticals into clinically relevant drugs for the diagnosis and treatment of cancer, cardiovascular and other diseases,” the release said.
A spokesperson told Becker’s the facility is forecasted to be about 14,500 square feet.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.